Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Viberti G, Kahn SE, Greene DA, Herman WH, Zinman B, Holman RR, Haffner SM, Levy D, Lachin JM, Berry RA, Heise MA, Jones NP, Freed MI. Viberti G, et al. Among authors: freed mi. Diabetes Care. 2002 Oct;25(10):1737-43. doi: 10.2337/diacare.25.10.1737. Diabetes Care. 2002. PMID: 12351470 Clinical Trial.
Rosiglitazone monotherapy is effective in patients with type 2 diabetes.
Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI; Rosiglitazone Clinical Trials Study Group. Lebovitz HE, et al. Among authors: freed mi. J Clin Endocrinol Metab. 2001 Jan;86(1):280-8. doi: 10.1210/jcem.86.1.7157. J Clin Endocrinol Metab. 2001. PMID: 11232013 Clinical Trial.
44 results